Cyclin-Dependent Kinase 4 6 Inhibitors in Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer: Efficacy, Safety, and Clinical Integration. CDF 2024, 53 (03), 6759-6769. https://doi.org/10.48047/xjqvkf88.